4.6 Article

Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNAVaccination

Related references

Note: Only part of the references are listed.
Editorial Material Obstetrics & Gynecology

Considerations for COVID-19 Vaccination in Lactation

Alison Stuebe

BREASTFEEDING MEDICINE (2021)

Article Cell Biology

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Zijun Wang et al.

Summary: The IgA response to SARS-CoV-2 was characterized in a cohort of 149 convalescent individuals after COVID-19 diagnosis. IgA responses in plasma generally correlated with IgG responses, and B cells producing IgM, IgG, and IgA were derived from common progenitor cells. Notably, IgA dimers were found to be 15 times more potent than IgA monomers against SARS-CoV-2, suggesting their potential value for protection and vaccine efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Immunology

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

Alberto Cagigi et al.

Summary: In this concise review, the concepts behind mRNA vaccination, the innate and adaptive immune response generated by mRNA vaccines in different animal models and in humans, examples of viral infections where mRNA vaccines have shown to induce potent responses, and the recent SARS-CoV-2 mRNA vaccine trials in humans are summarized.

VACCINES (2021)

Article Biochemistry & Molecular Biology

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Elizabeth M. Anderson et al.

Summary: Our research indicates that most individuals had antibodies against other seasonal human coronaviruses before the COVID-19 pandemic. Around 20% of these individuals also had antibodies that cross-reacted with SARS-CoV-2, but these antibodies did not offer protection against SARS-CoV-2 infections or hospitalizations.
Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Letter Medicine, General & Internal

Neutralizing Activity of BNT162b2-Elicited Serum

Yang Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Microbiology

Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19

Ryan M. Pace et al.

Summary: This study did not detect SARS-CoV-2 RNA in breast milk samples, indicating no transmission of the virus through milk. Breast milk from infected mothers contains anti-SARS-CoV-2 IgA and IgG, which neutralizes the virus and supports the recommendation to continue breastfeeding during maternal COVID-19 illness.
Article Obstetrics & Gynecology

Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study

Kathryn J. Gray et al.

Summary: The study found that pregnant and lactating women had equivalent antibody titers after receiving the coronavirus disease 2019 mRNA vaccine compared to nonpregnant women, and these titers were higher than those induced by natural infection. Vaccine-induced antibodies were present in umbilical cord blood and breastmilk samples, transferring immunity to neonates through placenta and breastmilk.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Editorial Material Obstetrics & Gynecology

Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination

Jeannie C. Kelly et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Letter Medicine, General & Internal

SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women

Sivan Haia Perl et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Ai-ris Y. Collier et al.

Summary: This study assessed the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, as well as the responses against emerging SARS-CoV-2 variants. The results showed that pregnant, lactating, and nonpregnant women developed antibody and T-cell responses following vaccination, with antibodies transferred to infant cord blood and breast milk. While antibody titers against the B.1.1.7 and B.1.351 variants were reduced, T-cell responses remained against the viral variants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Obstetrics & Gynecology

Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Naima T. Joseph et al.

Summary: Following SARS-CoV-2 infection during pregnancy, pregnant women showed robust maternal neutralizing and anti-receptor-binding domain IgG response, but a lower-than-expected efficiency of transplacental antibody transfer was observed, along with a significant reduction in neutralization between maternal blood and cord blood. Maternal infection does confer some degree of neonatal antibody protection, but the robustness and durability of this protection need further study.

OBSTETRICS AND GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers

Vivian Valcarce et al.

Summary: This study found significant secretion of SARS-CoV-2-specific IgA and IgG in human milk and plasma after SARS-CoV-2 vaccination, indicating that mRNA-based COVID-19 vaccines induce specific IgA and IgG secretion in human milk. Further research is needed to determine the duration and efficacy of this immune response, as well as the potential therapeutic use of human milk IgA in combating SARS-CoV-2 infections and COVID-19.

BREASTFEEDING MEDICINE (2021)

Article Obstetrics & Gynecology

Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2

Vignesh Narayanaswamy et al.

Summary: The study found a strong humoral immune response in the colostrum of women infected with SARS-CoV-2, with differences in inflammatory markers between symptomatic and asymptomatic cases.

BREASTFEEDING MEDICINE (2021)

Article Nursing

SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination

Jill K. Baird et al.

Summary: The study found that maternal vaccination against SARS-CoV-2 resulted in the presence of protective specific immunoglobulins in human milk that began to significantly increase around 7 days after vaccination, with an IgG-dominant response.

JOURNAL OF HUMAN LACTATION (2021)

Article Obstetrics & Gynecology

COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study

Nadia Charepe et al.

Summary: This study investigated the transfer of antibodies through breastmilk in lactating women after receiving the Pfizer vaccine. Results showed that all women had immunity post-vaccination, with IgG being the dominant serum antibody response. Modest levels of antibodies, especially IgG, were observed in breastmilk of lactating mothers. High IgG titers were moderately associated with longer duration of breastfeeding. More research is needed to establish the immunization potential through breastfeeding.

BMC PREGNANCY AND CHILDBIRTH (2021)

Article Cell Biology

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng et al.

Summary: The Delta H69N70 mutation in SARS-CoV-2 spike protein increases infectivity and partially rescues immune escape mutations that impair infectivity. Continued surveillance and research on deletions with functional effects are necessary.

CELL REPORTS (2021)

Article Environmental Sciences

Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain

Carolina Lechosa-Muniz et al.

Summary: This study found that all vaccinated breastfeeding mothers produced antibodies against the SARS-CoV-2 vaccine, regardless of the commercial vaccine used. Additionally, breastfeeding mothers provide their infants with IgA and IgG antibodies against the SARS-CoV-2 protein S through breast milk.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Critical Care Medicine

BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers

Yaniv Lustig et al.

Summary: The study assessed early antibody responses after Pfizer-BioNTech BNT162b2 COVID-19 vaccine in Israeli healthcare workers. Results showed that 77% of participants had positive IgG response at week 3 after the first vaccine dose, with lower responses in older and immunosuppressed individuals. Timely second dose vaccinations are particularly important for these populations to enhance antibody responses and reduce breakthrough infections.

LANCET RESPIRATORY MEDICINE (2021)

Article Immunology

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees

Jia Ming Low et al.

Summary: Lactating mothers who received the BNT162b2 vaccine secreted SARS-CoV-2-specific antibodies into milk, providing protective immunity. Minimal transfer of vaccine mRNA was detected, and no adverse effects were reported in recipients.

NPJ VACCINES (2021)

Review Allergy

Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention

Dhavalkumar D. Patel et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Nursing

Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection

Cibele Wolf Lebrao et al.

JOURNAL OF HUMAN LACTATION (2020)

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Review Immunology

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19

Gideon Schreiber

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk

Alisa Fox et al.

ISCIENCE (2020)

Article Gastroenterology & Hepatology

Changes in Proteases, Antiproteases, and Bioactive Proteins From Mother's Breast Milk to the Premature Infant Stomach

Veronique Demers-Mathieu et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)